Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific stent patent prevails

This article was originally published in The Gray Sheet

Executive Summary

U.S. District Court for Delaware June 15 upholds a 2005 jury determination that Johnson & Johnson/Cordis' Cypher sirolimus-eluting stent infringes Boston Scientific's "Ding" patent for non-thrombogenic polymer technology. Cordis had asked the court to overturn the 2005 jury verdict and now says it will appeal the decision by District Court Judge Sue Robinson (1"The Gray Sheet" July 4, 2005, p. 5). The ruling is Robinson's third in six weeks on patent disputes between the sparring drug-eluting stent manufacturers. Prudential Equity Group senior medical device analyst Larry Biegelsen said in a June 15 research note that the continuing stent intellectual property battle between the two firms is "unlikely to have a substantial financial impact on either party"...
Advertisement

Related Content

Boston Scientific loses appeal in J&J case
No Summer Break? Legal, Enforcement Issues Tax Boston Scientific Counsel
No Summer Break? Legal, Enforcement Issues Tax Boston Scientific Counsel
Advertisement
UsernamePublicRestriction

Register

MT023667

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel